[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [BUSINESS]

2 clusters · 2 sources · 17 days · First seen · Last updated

Neuroscience company earnings and analyst updates

Overview

Analysts have updated earnings per share (EPS) estimates for neuroscience-focused companies Promis Neurosciences and NeuroPace.

Brookline Capital Markets raised the Q3 2026 EPS forecast for Promis Neurosciences to ($1.29) from ($2.41), following a reported Q3 loss of ($1.28) per share which exceeded consensus estimates. The firm maintains a ‘Strong-Buy’ rating.

Meanwhile, HC Wainwright lowered its Q3 2027 EPS estimate for NeuroPace to $0.05 per share from $0.06, while maintaining a ‘Buy’ rating and a $20.00 price objective.

Entities

Cooper Standard Ltd. · NeuroOne Medical Technologies Corporation · Eton Pharmaceuticals · HC Wainwright · NeuroPace

Timeline

  1. 6 days ago

    [BUSINESS] 2 sources
    Promis Neurosciences and NeuroPace see updated analyst earnings estimates

    Analysts have adjusted earnings per share estimates for Promis Neurosciences and NeuroPace, with Brookline Capital Markets raising forecasts for the former and HC Wainwright lowering them for the latter.

  2. 22 days ago

    [BUSINESS] 7 sources
    NeuroOne, Paylocity, Neuronetics, Personalis, and Cooper Standard Schedule Upcoming Earnings Calls

    NeuroOne, Paylocity, Neuronetics, Personalis, and Cooper Standard announce upcoming earnings releases and investor webcast events in August 2026.

Sources

mommygearest.com · stocknews.com